Glixx Laboratories Inc
Your exclusive source for bioactive molecules
Glixx Laboratorie
CAS: N/A
Chemical Name: 19-tert-Butyldiphenylsilyl-8,7-epoxy andrographolide; (4S,E)-3-(2-((1S,2S,5R,6R,8aR)-5-(((tert-Butyldiphenylsilyl)oxy)methyl)-6-hydroxy-5,8a-dimethyloctahydro-1H-spiro[naphthalene-2,2'-oxiran]-1-yl)ethylidene)-4-hydroxydihydrofuran-2(3H)-one
Purity: >98% (HPLC)
Novel anticancer agent against metastatic Castration resistance and neuroendocrine variant prostate cancers (mCRPC/NEPC), exhibiting synergistic anticancer effect in combination with standard therapy docetaxel and cabazitaxel in mCRPC/NEPC, upregulating Heat Shock proteins and downregulating MAT2A-mediated cell migration and invasion
Ref: https://jpet.aspetjournals.org/content/early/2021/12/23/jpet.121.000898
Place an order!
POA | |||
Bulk inquiry contact: | |||
sales@glixxlabs.com |
|||
service@glixxlabs.com |